The wash-out technique in the management of delayed presentations of extravasation injuries

Journal of Hand Surgery: European Volume

Volumn 36, Issue 1, 2011, Pages 66-69

  Dionyssiou, D ^a   Chantes, A ^a   Gravvanis, A ^a   Demiri, E ^a  

^a Department of Plastic Surgery   (Greece)

Author keywords

Delayed presentation; Extravasation; Wsh out technique

Indexed keywords

ANTINEOPLASTIC AGENT; DOXORUBICIN; EPIRUBICIN;

ADULT; AGED; ARM; ARTICLE; CONTRAST MEDIUM EXTRAVASATION; DELAYED DIAGNOSIS; DRUG EFFECT; FEMALE; FOLLOW UP; HAND; HUMAN; LAVAGE; MALE; MIDDLE AGED; WOUND HEALING;

ADULT; AGED; ANTINEOPLASTIC AGENTS; ARM; DELAYED DIAGNOSIS; DOXORUBICIN; EPIRUBICIN; EXTRAVASATION OF DIAGNOSTIC AND THERAPEUTIC MATERIALS; FEMALE; FOLLOW-UP STUDIES; HAND; HUMANS; MALE; MIDDLE AGED; THERAPEUTIC IRRIGATION; WOUND HEALING;

EID: 79952841365     PISSN: 17531934     EISSN: 20436289     Source Type: Journal    
DOI: 10.1177/1753193410379553     Document Type: Article

References (22)

1. Bertelli G, Gozza A, Forno GB et al. Topical dimethyl sulfoxide for the prevention of soft tissue injury after extravasation of vesicant drugs: a prospective clinical study. J Clin Oncol. 1995, 13: 2851-5.
2. Bowers DG, Lynch JB. Adriamycin extravasation. Plast Reconstr Surg. 1978, 61: 86-92. (Pubitemid 9041013)
3. Dorr T. Antidotes to vesicant chemotherapy extravasation. Blood Rev. 1990, 4: 41-60.
4. Ener RA, Meglathery SB, Styler M. Extravasation of systemic hematooncological therapies. Ann Oncol. 2004, 15: 858-62.
5. Fleming A, Butler B, Gault D. Surgical management after doxorubicin and epirubicin extravasation. J Hand Surg Br. 1999, 24: 390.
6. Gault DT. Extravasation injuries. Br J Plast Surg. 1993, 46: 91-6. (Pubitemid 23116051)
7. Giunta R. Early subcutaneous wash-out in acute extravasations. Ann Oncol. 2004, 15: 1146.
8. Giunta R, Akpaloo J, Kovacs L, Biemer E. Subcutaneous 'wash-out' in extravasations. Handchir Mikrochir Plast Chir. 2002, 34: 399-402.
9. Heckler FR. Current thoughts on extravasation injuries. Clinics Plastic Surg. 1989, 16: 557-63. (Pubitemid 19214817)
10. Heitmann C, Durmus C, Ingianni G. Surgical management after doxorubicin and epirubicin extravasation. J Hand Surg Br. 1998, 23: 666-8. (Pubitemid 28484705)
11. Langstein HN, Duman H, Seeling D, Butler CE, Evans GR. Retrospective study of the management of chemotherapeutic extravasation injury. Ann Plast Surg. 2002, 49: 369-74.
12. Larson D. Treatment of tissue extravasation by antitumor agents. Cancer. 1982, 49: 1796-9. (Pubitemid 12153449)
13. Larson D. What is the appropriate management of tissue extravasation by antitumour agents? Plast Reconstr Surg. 1985, 75: 397-402. (Pubitemid 15143600)
14. Laughlin RA, Landeen JM, Habal MB. The management of inadvertent subcutaneous adriamycin infiltration. Am J Surg. 1979, 137: 408-12.
15. Morykwas MJ, Kennedy A, Argenta JP, Argenta LC. Use of subatmospheric pressure to prevent doxorubicin extravasation ulcers in a swine model. J Surg Oncol. 1999, 72: 14-17. (Pubitemid 29446935)
16. Preuss P, Partoft S. Cytostatic extravasations. Ann Plast Surg. 1987, 19: 323-7.
17. Rudolph R, Larson DL. Etiology of chemotherapeutic agent extravasation injuries: a review. J Clin Oncol. 1987, 5: 1116-26. (Pubitemid 18056020)
18. Schrijvers DL. Extravasation: a dreaded complication of chemotherapy. Ann Oncol. 2003, 14(Suppl. 3): 26-30.
19. Thakur JS, Chauhan CG, Diwana VK, Chauhan DC, Thakur A. Extravasational side effects of cytotoxic drugs: a preventable catastrophe. Indian J Plast Surg. 2008, 41: 145-50.
20. Tsavaris NB, Karagiaouris P, Tzannou I et al. Conservative approach to the treatment of chemotherapy-induced extravasation. J Dermatol Surg Oncol. 1990, 16: 519-22. (Pubitemid 20227031)
21. Tsavaris NB, Komitsopoulou P, Karagiaouris P et al. Prevention of tissue necrosis due to accidental extravasation of cytostatic drugs by a conservative approach. Cancer Chemother Pharmacol. 1992,30: 330-3.
22. Upton J, Mulliken JB, Murray JE. Major intravenous extravasation injuries. Am J Surg. 1979, 137: 497-506. (Pubitemid 9147256)